Early and accurate diagnosis of Alzheimer's Disease is pivotal for effective intervention. Recent advancements in biomarkers, including CSF and PET imaging, are transforming the diagnostic landscape.

Alzheimer's disease disproportionately affects Black people, presenting a complex interplay of genetic, social, and systemic factors. This article delves into the epidemiological evidence and underlying mechanisms driving these health disparities, advocating for a multi-faceted research approach.